Trial · NCT02443545
Adverse events52
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 52
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Sickle cell anaemia with crisis | Blood and lymphatic system disorders | Deferiprone | 17 | 134 | 39 |
| other | Abdominal pain | Gastrointestinal disorders | Deferiprone | 26 | 134 | 44 |
| other | Vomiting | Gastrointestinal disorders | Deferiprone | 9 | 134 | 12 |
| other | Pyrexia | General disorders | Deferiprone | 33 | 134 | 50 |
| other | Nasopharyngitis | Infections and infestations | Deferiprone | 17 | 134 | 28 |
| other | Pharyngitis | Infections and infestations | Deferiprone | 10 | 134 | 15 |
| other | Upper respiratory tract infection | Infections and infestations | Deferiprone | 9 | 134 | 12 |
| other | Neutrophil count decreased | Investigations | Deferiprone | 16 | 134 | 29 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Deferiprone | 10 | 134 | 15 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Deferiprone | 17 | 134 | 51 |
| other | Bone pain | Musculoskeletal and connective tissue disorders | Deferiprone | 35 | 134 | 97 |
| other | Musculoskeletal pain | Musculoskeletal and connective tissue disorders | Deferiprone | 9 | 134 | 11 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Deferiprone | 18 | 134 | 33 |
| other | Headache | Nervous system disorders | Deferiprone | 12 | 134 | 23 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Deferiprone | 7 | 134 | 10 |
| other | Oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | Deferiprone | 18 | 134 | 28 |
| serious | Agranulocytosis | Blood and lymphatic system disorders | Deferiprone | 2 | 134 | 2 |
| serious | Neutropenia | Blood and lymphatic system disorders | Deferiprone | 12 | 134 | 15 |
| serious | Sickle cell anaemia with crisis | Blood and lymphatic system disorders | Deferiprone | 19 | 134 | 42 |
| serious | Thrombocytopenia | Blood and lymphatic system disorders | Deferiprone | 1 | 134 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02443545/events